FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072736479> ?p ?o ?g. }

• W2072736479 endingPage "569" @default.
• W2072736479 startingPage "565" @default.
• W2072736479 abstract "The early results of liver transplantations (OLT) in patients with advanced hepatocellular carcinoma (HCC) were poor because of frequent tumor recurrence. However, OLT has significant, theoretical advantage that it removes both the tumor and the organ that is at a risk of malignancy. The Japanese law on organ transplantation limited the availability of cadaveric liver donors until its revision on July 17, 2011. ABO-incompatible OLT was formerly contraindicated because performed anti-A/B antibodies on recipient endothelial cells raised the risk of antibody-mediated humoral graft rejection. We have herein described four successful cases of steroid withdrawal among adult patients who underwent living donor OLT from ABO-incompatible donors. In addition, we transplanted a liver from a living donor into an ABO-incompatible recipient on August 9, 2004. The 55-year-old man with HCC due to hepatitis B virus (HBV) a cirrhosis had a Child-Pugh score of C, and Model for End-stage Liver Disease score of 22. Two tumors greater than 5 cm, exceeded the Milan criteria. His des-gamma-carboxy prothrombin level was 6 mAu/mL, and alpha-fetoprotein, 18.78 ng/mL. Antirejection therapy included multiple perioperative plasmaphereses and splenectomy; with an immunosuppressive regimen consisting of tacrolimus, methylprednisolone, and mycophenolate mofetil. The maintenance dose of immunosuppression did not differ from that of ABO-identical cases. After transplantation, we used intrahepatic arterial infusion therapy with prostaglandin E1 (PG E1). The patient had complications of portal vein thrombosis, hepatic artery thrombosis, and acute myocardial infarction, which were treated by interventional radiology in the posttransplantation period. We controlled the HBsAb titer by administering hepatitis B immunoglobulin and lamivudine (200 IU/L doses) for 1 year after OLT and 100 IU/L doses thereafter. As a result, the patient achieved long-term, disease-free graft survival without steroids. He currently has good liver function and leads a normal lifestyle. Our results suggested the feasibility of controlling antibody-mediated humoral rejection and other complications in living donor liver transplantations into ABO-incompatible adults via intrahepatic arterial PG E1 infusion splenectomy, and plasmapheresis with regular immunosuppression. Withdrawal of steroids, HBV vaccination, and lamivudine, an nucleoside analog reverse transcriptase inhibitor, have achieved long-term (7 years) survival without recurrent HBV infection or tumor." @default.
• W2072736479 created "2016-06-24" @default.
• W2072736479 creator A5006983397 @default.
• W2072736479 creator A5023897976 @default.
• W2072736479 creator A5040114902 @default.
• W2072736479 creator A5044253082 @default.
• W2072736479 creator A5053765147 @default.
• W2072736479 creator A5058306123 @default.
• W2072736479 creator A5078571989 @default.
• W2072736479 creator A5079398725 @default.
• W2072736479 date "2012-03-01" @default.
• W2072736479 modified "2023-10-09" @default.
• W2072736479 title "Long-Term Recurrence-Free Survival After Liver Transplantation from an ABO-Incompatible Living Donor for Treatment of Hepatocellular Carcinoma Exceeding Milano Criteria in a Patient With Hepatitis B Virus Cirrhosis: A Case Report" @default.
• W2072736479 cites W1488650326 @default.
• W2072736479 cites W1973008647 @default.
• W2072736479 cites W2000316050 @default.
• W2072736479 cites W2020450932 @default.
• W2072736479 cites W2022125473 @default.
• W2072736479 cites W2047220253 @default.
• W2072736479 cites W2061056969 @default.
• W2072736479 cites W2079621659 @default.
• W2072736479 cites W2109242135 @default.
• W2072736479 cites W2131749577 @default.
• W2072736479 cites W2154326996 @default.
• W2072736479 cites W2315027248 @default.
• W2072736479 doi "https://doi.org/10.1016/j.transproceed.2012.01.029" @default.
• W2072736479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22410070" @default.
• W2072736479 hasPublicationYear "2012" @default.
• W2072736479 type Work @default.
• W2072736479 sameAs 2072736479 @default.
• W2072736479 citedByCount "6" @default.
• W2072736479 countsByYear W20727364792013 @default.
• W2072736479 countsByYear W20727364792015 @default.
• W2072736479 countsByYear W20727364792016 @default.
• W2072736479 countsByYear W20727364792018 @default.
• W2072736479 crossrefType "journal-article" @default.
• W2072736479 hasAuthorship W2072736479A5006983397 @default.
• W2072736479 hasAuthorship W2072736479A5023897976 @default.
• W2072736479 hasAuthorship W2072736479A5040114902 @default.
• W2072736479 hasAuthorship W2072736479A5044253082 @default.
• W2072736479 hasAuthorship W2072736479A5053765147 @default.
• W2072736479 hasAuthorship W2072736479A5058306123 @default.
• W2072736479 hasAuthorship W2072736479A5078571989 @default.
• W2072736479 hasAuthorship W2072736479A5079398725 @default.
• W2072736479 hasConcept C126322002 @default.
• W2072736479 hasConcept C141071460 @default.
• W2072736479 hasConcept C2776282453 @default.
• W2072736479 hasConcept C2777214474 @default.
• W2072736479 hasConcept C2778019345 @default.
• W2072736479 hasConcept C2778800853 @default.
• W2072736479 hasConcept C2779609443 @default.
• W2072736479 hasConcept C2780252810 @default.
• W2072736479 hasConcept C2911091166 @default.
• W2072736479 hasConcept C71924100 @default.
• W2072736479 hasConcept C90924648 @default.
• W2072736479 hasConceptScore W2072736479C126322002 @default.
• W2072736479 hasConceptScore W2072736479C141071460 @default.
• W2072736479 hasConceptScore W2072736479C2776282453 @default.
• W2072736479 hasConceptScore W2072736479C2777214474 @default.
• W2072736479 hasConceptScore W2072736479C2778019345 @default.
• W2072736479 hasConceptScore W2072736479C2778800853 @default.
• W2072736479 hasConceptScore W2072736479C2779609443 @default.
• W2072736479 hasConceptScore W2072736479C2780252810 @default.
• W2072736479 hasConceptScore W2072736479C2911091166 @default.
• W2072736479 hasConceptScore W2072736479C71924100 @default.
• W2072736479 hasConceptScore W2072736479C90924648 @default.
• W2072736479 hasIssue "2" @default.
• W2072736479 hasLocation W20727364791 @default.
• W2072736479 hasLocation W20727364792 @default.
• W2072736479 hasOpenAccess W2072736479 @default.
• W2072736479 hasPrimaryLocation W20727364791 @default.
• W2072736479 hasRelatedWork W2002131373 @default.
• W2072736479 hasRelatedWork W2083124691 @default.
• W2072736479 hasRelatedWork W2118865824 @default.
• W2072736479 hasRelatedWork W2466683206 @default.
• W2072736479 hasRelatedWork W2786622875 @default.
• W2072736479 hasRelatedWork W3196574812 @default.
• W2072736479 hasRelatedWork W3202544346 @default.
• W2072736479 hasRelatedWork W3208362189 @default.
• W2072736479 hasRelatedWork W4232720482 @default.
• W2072736479 hasRelatedWork W2624780540 @default.
• W2072736479 hasVolume "44" @default.
• W2072736479 isParatext "false" @default.
• W2072736479 isRetracted "false" @default.
• W2072736479 magId "2072736479" @default.
• W2072736479 workType "article" @default.